We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+8.77%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
AUM
$5.53B
AUM Growth
+$590M
Cap. Flow
+$155M
Cap. Flow %
2.79%
Top 10 Hldgs %
22.88%
Holding
313
New
33
Increased
112
Reduced
69
Closed
58

Sector Composition

Rank Sector Weight
1 Healthcare 24.54%
2 Technology 23.84%
3 Financials 21.07%
4 Communication Services 10.37%
5 Consumer Discretionary 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HR
201
DELISTED
Healthcare Realty Trust Incorporated
HR
$1.7M 0.03%
60,000
TU icon
202
Telus
TU
$16.2B
$1.69M 0.03%
99,000
NVDQ
203
DELISTED
Novadaq Technologies Inc.
NVDQ
$1.65M 0.03%
130,000
TWO
204
Two Harbors Investment
TWO
$1.27B
$1.62M 0.03%
25,000
+2,500
+11% +$171K
CVS icon
205
CVS Health
CVS
$137B
$1.61M 0.03%
16,500
+2,000
+14% +$196K
PCRX icon
206
Pacira BioSciences
PCRX
$1.04B
$1.61M 0.03%
20,989
+6,099
+41% +$345K
NHI icon
207
National Health Investors
NHI
$3.84B
$1.52M 0.03%
25,000
SBRA icon
208
Sabra Healthcare REIT
SBRA
$5.65B
$1.52M 0.03%
75,000
ALLT icon
209
Allot
ALLT
$373M
$1.51M 0.03%
260,417
-93,869
-26% -$518K
ACOR
210
DELISTED
Acorda Therapeutics
ACOR
$1.51M 0.03%
294
-96
-25% -$420K
DHC
211
Diversified Healthcare Trust
DHC
$2.28B
$1.48M 0.03%
100,000
-900
-0.9% -$13.5K
ATHN
212
DELISTED
Athenahealth, Inc.
ATHN
$1.45M 0.03%
9,000
+733
+9% +$113K
SUPN icon
213
Supernus Pharmaceuticals
SUPN
$2.73B
$1.43M 0.03%
106,021
-48,922
-32% -$757K
SHPG
214
DELISTED
Shire pic
SHPG
$1.4M 0.03%
6,823
+2,270
+50% +$472K
MDVN
215
DELISTED
MEDIVATION, INC.
MDVN
$1.37M 0.02%
28,302
+15,161
+115% +$654K
HCSG icon
216
Healthcare Services Group
HCSG
$1.58B
$1.34M 0.02%
38,372
MTLS
217
Materialise
MTLS
$373M
$1.2M 0.02%
170,631
+2,700
+2% +$21.5K
AGU
218
DELISTED
Agrium
AGU
$1.12M 0.02%
12,500
-4,700
-27% -$445K
CSLT
219
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$1.11M 0.02%
+261,458
New +$1.12M
HDB icon
220
HDFC Bank
HDB
$119B
$1.1M 0.02%
71,608
CASH icon
221
Pathward Financial
CASH
$1.82B
$977K 0.02%
63,798
+17,076
+37% +$249K
MO icon
222
Altria Group
MO
$122B
$902K 0.02%
15,500
VIVO
223
DELISTED
Meridian Bioscience Inc
VIVO
$878K 0.02%
42,800
MA icon
224
Mastercard
MA
$487B
$813K 0.01%
8,350
-141,325
-94% -$13.8M
APIC
225
DELISTED
Apigee Corporation Common Stock
APIC
$807K 0.01%
100,629
-131,100
-57% -$1.14M

Similar funds

Polar Capital's Q4 2015 Portfolio in Review

As of Q4 2015, Polar Capital held 313 positions worth $5.53B, up 12% from $4.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Polar Capital's Q4 2015 filing shows 33 new, 112 increased, 69 reduced and 58 closed positions. Its largest new stake was Alphabet (Google) Class A: 2,541,420 shares worth $98.9M. The largest sale was Pfizer, an estimated $77.3M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 26% a quarter earlier, followed by Technology and Financials.

  • Polar Capital's largest Q4 2015 buy was Alphabet (Google) Class A: 2,541,420 shares worth $98.9M.
  • Polar Capital added most to Johnson & Johnson in Q4 2015, an estimated $94.4M increase.
  • Polar Capital's biggest Q4 2015 reduction was Pfizer, cutting an estimated $77.3M.
  • Polar Capital fully exited Walgreens Boots Alliance in Q4 2015, selling an estimated $32.1M.
  • Polar Capital's ten largest holdings make up 23% of its $5.53B portfolio in Q4 2015.
  • Polar Capital opened 33 new positions and closed 58 in Q4 2015.
  • Polar Capital's portfolio value rose 12% quarter-over-quarter to $5.53B.

Based on Polar Capital's 13F filing for Q4 2015, filed 16 Feb 2016.